In yesterday’s Wall Street session, Agilon Health Inc (NYSE:AGL) shares traded at $3.69, up 3.94% from the previous session.
AGL stock price is now 68.93% away from the 50-day moving average and -13.89% away from the 200-day moving average. The market capitalization of the company currently stands at $1.52B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $1.75 to $2.25, Citigroup Upgraded its rating from Sell to Neutral for Agilon Health Inc (NYSE: AGL). , while ‘Macquarie’ rates the stock as ‘Neutral’
In other news, McLoughlin Karen, Director bought 25,000 shares of the company’s stock on Dec 13 ’24. The stock was bought for $55,085 at an average price of $2.20. Upon completion of the transaction, the Director now directly owns 73,166 shares in the company, valued at $0.27 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 11 ’24, Director Battaglia Silvana bought 25,062 shares of the business’s stock. A total of $50,269 was incurred on buying the stock at an average price of $2.01. This leaves the insider owning 66,144 shares of the company worth $0.24 million. A total of 26.39% of the company’s stock is owned by insiders.
During the past 12 months, Agilon Health Inc has had a low of $1.50 and a high of $7.73. As of last week, the company has a debt-to-equity ratio of 0.08, a current ratio of 1.29, and a quick ratio of 1.29. The fifty day moving average price for AGL is $2.1664 and a two-hundred day moving average price translates $4.2905 for the stock.
The latest earnings results from Agilon Health Inc (NYSE: AGL) was released for 2024-09-30. The net profit margin was -6.01% and return on equity was -42.98% for AGL. The company reported revenue of $1.45 billion for the quarter, compared to $1.14 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 27.63 percent. For the current quarter, analysts expect AGL to generate $1.52B in revenue.
